Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112932 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zhou-Shan Tao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, P…. Hauptthemen laut MEDLINE: Valproic Acid, Oxidative Stress, Melatonin, Osteoporosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Education Revitalization Project of Anhui Province, Science Research Foundation of Zhejiang Province.
Abstract (Originalsprache)
Melatonin (MEL) has shown positive effects in anti-inflammatory and anti-oxidative stress research. This study investigates whether MEL can positively impact bone loss induced by valproic acid (VPA) in rats. The study examines changes in MC3T3-E1 cell viability and osteogenic potential, along with osteoclast differentiation in RAW264.7 cells in the presence of VPA using CCK-8, ALP staining, AR staining, and TRAP staining. In vitro experiments reveal that VPA-induced inhibition of osteogenic differentiation and promotion of osteoclastic differentiation are linked to increased inflammation and oxidative stress. Furthermore, MEL has demonstrated the ability to reduce oxidative stress and inflammation, boost osteogenic differentiation, and inhibit osteoclast differentiation. Animal experiments confirm that MEL significantly increases SOD2 expression and decreases TNF-α expression, leading to the restoration of impaired bone metabolism, enhanced bone strength, and higher bone mineral density. The combined experimental results strongly suggest that MEL can enhance osteogenic activity in the presence of VPA by reducing inflammation and oxidative stress, impeding osteoclast differentiation, and alleviating bone loss in VPA-treated rat models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, PR China; Anhui Province Key Laboratory of Non-coding RNA Basic and Cli…
- Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, PR China.
- Department of Orthopedics, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, No. 289, Kuocang Road, Lishui City 323000, ZheJiang, PR China. Electronic address: suntao20242024@163.com.
Förderung
- Education Revitalization Project of Anhui Province
- Science Research Foundation of Zhejiang Province
Zitieren
APA
Tao, Z. S., Hu, X. F., & Sun, T. (2024). Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112932
Vancouver
Tao ZS, Hu XF, Sun T. Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112932
BibTeX
@article{Tao2024,
author = {Tao, Zhou-Shan and Hu, Xu-Feng and Sun, Tao},
title = {Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112932}
}
EUVIMED